Biosynex SA (EPA: ALBIO)

Biosynex Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5.41	20.17	87.17	132.03	36.84	1.9
Short-Term Investments	5.33	6	-	-	-	0.61
Cash & Short-Term Investments	10.74	26.16	87.17	132.03	36.84	2.51
Cash Growth	-76.29%	-69.99%	-33.98%	258.43%	1368.38%	26.81%
Accounts Receivable	10.2	10.65	14.7	25.27	11.49	2.83
Other Receivables	4.7	5.84	14.09	6.08	5.78	1.83
Receivables	14.9	16.49	28.79	31.35	17.27	4.66
Inventory	37.51	38.21	37.67	31.15	32.55	7.82
Prepaid Expenses	2.79	2.93	1.43	1.05	-	-
Other Current Assets	1.83	1.9	3.35	2.27	-	-
Total Current Assets	72.4	91.35	159.61	198.78	87.53	16.07
Property, Plant & Equipment	12.41	11.94	6.38	3.44	2.36	1
Long-Term Investments	0.42	0.47	2.57	3.28	1.98	-
Goodwill	79.01	91.54	60.91	46.24	29.27	27.59
Other Intangible Assets	20.84	39.8	25.95	5.89	1.28	1.3
Long-Term Deferred Charges	15.61	-	-	-	0.63	0.34
Other Long-Term Assets	8.07	6.63	4.93	11.31	3.02	0.7
Total Assets	208.75	241.73	260.34	268.94	126.07	47
Accounts Payable	15.45	15.07	14.99	18.73	19.59	3.68
Accrued Expenses	6.34	6.19	6.62	7.64	6.64	-
Short-Term Debt	0.37	0.24	0.04	0.04	0.05	0.01
Current Portion of Long-Term Debt	50.61	5.6	49.48	0.15	5.96	-
Current Portion of Leases	1.53	0.55	1.41	-	-	-
Current Income Taxes Payable	0.01	0.01	1.73	19.81	13.65	1.93
Current Unearned Revenue	0.73	0.51	0.22	1.94	0.07	-
Other Current Liabilities	6.96	9.17	8.36	12.45	3.11	-
Total Current Liabilities	85.84	40.82	83.86	61.32	49.08	5.62
Long-Term Debt	10.52	58.28	1.15	34.08	9.75	9.68
Long-Term Leases	-	1.29	-	1.04	-	-
Other Long-Term Liabilities	9.18	17.02	8.43	4.69	0.95	1.17
Total Liabilities	105.54	117.41	93.45	101.14	59.78	16.48
Common Stock	1.08	1.08	1.03	1.11	0.92	0.91
Additional Paid-In Capital	25.6	25.6	25.6	47.27	27.9	27.71
Retained Earnings	96.21	55.31	77.08	130.92	31.46	1.19
Comprehensive Income & Other	-19.63	42.49	58.83	-11.5	6.01	0.7
Total Common Equity	103.25	124.48	162.53	167.81	66.29	30.52
Minority Interest	-0.04	-0.17	4.37	-	-	-
Shareholders' Equity	103.21	124.32	166.9	167.81	66.29	30.52
Total Liabilities & Equity	208.75	241.73	260.34	268.94	126.07	47
Total Debt	63.03	65.96	52.08	35.31	15.77	9.69
Net Cash (Debt)	-52.29	-39.8	35.1	96.72	21.07	-7.19
Net Cash Growth	-	-	-63.72%	359.13%	-	-
Net Cash Per Share	-4.72	-3.72	3.41	9.31	2.36	-0.79
Filing Date Shares Outstanding	10.76	10.76	10.25	10.32	10.04	9.14
Total Common Shares Outstanding	10.76	10.76	10.25	10.32	9.15	9.14
Working Capital	-13.44	50.53	75.75	137.45	38.45	10.45
Book Value Per Share	9.59	11.57	15.85	16.26	7.24	3.34
Tangible Book Value	3.4	-6.86	75.67	115.67	35.73	1.64
Tangible Book Value Per Share	0.32	-0.64	7.38	11.21	3.90	0.18
Buildings	0.49	0.09	-	-	-	-
Machinery	21.82	19.27	10.58	6.37	3.05	2.06
Construction In Progress	0.02	0.02	0.03	-	1.02	0.42

Source: S&P Capital IQ. Standard template. Financial Sources.